HIV Research & Clinical Practice, Volume 20, Issue 4-5 (2019)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

HIV Research & Clinical Practice, Volume 20, Issue 4-5 (2019)

See all volumes and issues
Vol 25, 2024 Vol 24, 2023 Vol 23, 2022 Vol 22, 2021 Vol 21, 2020 Volume 20, 2019 Vol 19, 2018 Vol 18, 2017 Vol 17, 2016 Vol 16, 2015 Vol 15, 2014 Vol 14, 2013 Vol 13, 2012 Vol 12, 2011 Vol 11, 2010 Vol 10, 2009 Vol 9, 2008 Vol 8, 2007 Vol 7, 2006 Vol 6, 2005 Vol 5, 2004 Vol 4, 2003 Vol 3, 2002 Vol 2, 2001 Vol 1, 2000
Download citations Download PDFs Download issue

Letter to the Editor

Letter
Characterization of low level viraemia in HIV-infected patients receiving boosted protease inhibitor-based antiretroviral regimens
Francesca Ferretti, Nicola E. Mackie, Gurmit Kaur Jagjit Singh, Julie Fox, Steve Kaye, Myra O. McClure, Graham Taylor & Marta Boffito
Pages: 107-110
Published online: 30 Jan 2020
AbstractforCharacterization of low level viraemia in HIV-infected patients receiving boosted protease inhibitor-based antiretroviral regimens | Full Text | References | PDF (238 KB)
  • 454 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Original Article

Article
Patient-reported tolerability and acceptability of cabotegravir + rilpivirine long-acting injections for the treatment of HIV-1 infection: 96-week results from the randomized LATTE-2 study
Miranda Murray, Federico Pulido, Anthony Mills, Moti Ramgopal, Roger LeBlanc, Hans Jaeger, Viviam Canon, David Dorey, Sandy Griffith, Joseph Mrus, William Spreen & David Margolis
Pages: 111-122
Published online: 18 Sep 2019
AbstractforPatient-reported tolerability and acceptability of cabotegravir + rilpivirine long-acting injections for the treatment of HIV-1 infection: 96-week results from the randomized LATTE-2 study | Full Text | References | PDF (740.2 KB)
  • 3148 Views
  • 17 CrossRef citations
  • 0Altmetric
Open Access

Brief Report

Brief Report
Cenicriviroc, a dual CCR2 and CCR5 antagonist leads to a reduction in plasma fibrotic biomarkers in persons living with HIV on antiretroviral therapy
S. Bowler, C. Siriwardhana, B. L. Mitchell, M. L. D’Antoni, D. Ogata-Arakaki, S. Souza, R. Yee, L. M. A. Gangcuangco, D. C. Chow, L. C. Ndhlovu & C. Shikuma
Pages: 123-129
Published online: 04 Feb 2020
AbstractforCenicriviroc, a dual CCR2 and CCR5 antagonist leads to a reduction in plasma fibrotic biomarkers in persons living with HIV on antiretroviral therapy | Full Text | References | PDF (415.3 KB)
  • 788 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Parenting with HIV: a patient’s view on updated infant feeding guidelines in the US
Ciarra Covin
Comment | Published online: 4 Jun 2024
Open Access
Weight change with antiretroviral switch from integrase inhibitor or tenofovir alafenamide-based to Doravirine-Based regimens in people with HIV
Arianna E. Kousari et al.
Article | Published online: 3 Jun 2024
Open Access
Understanding the lived experience research priorities for improving health-related quality of life in people living with HIV with cognitive impairment
Kate Alford et al.
Article | Published online: 3 Jun 2024
Open Access
Clinical characteristics and outcomes of people living with HIV and ocular syphilis during the COVID-19 health emergency
Edgar Pérez-Barragán et al.
Brief Report | Published online: 3 Jun 2024
Open Access